"Tom lived with the AbioCor, free of significant adverse events, for 512 days, well beyond any of the longevity expectations of our initial clinical trial," Lederman said. "For a good portion of that time he was at home with his family, free to travel and to engage as he wished in a wide variety of social activities."
What an incredible triumph. What a great civilization we are priviliged to enjoy.
10 posted on 02/08/2003 7:32:55 AM PST by Physicist